Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Recurrence 1Neuroblastoma 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Extranodal NK-T-Cell 1Hematologic Neoplasms 1Graft vs Host Disease 1

Interventions

selinexor 3pegaspargase 3Oxaliplatin 2Gemcitabine 2tislelizumab 1sugemalimab 1Thiotepa 1Radiotherapy 1Immune Checkpoint Inhibitors 1Azacitidine 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Lymphoma, Extranodal NK-T-Cell × Thiotepa × Clear all
NCT07276737 2025-12-11

Preconditioning With a Combination of Thiotepa, Cyclophosphamide, and Busulfan for Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of NK/T-Cell Lymphoma

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Not yet recruiting
37 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡